283 related articles for article (PubMed ID: 19786134)
1. Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention.
Schuring RP; Richardus JH; Pahan D; Oskam L
Vaccine; 2009 Nov; 27(50):7125-8. PubMed ID: 19786134
[TBL] [Abstract][Full Text] [Related]
2. Acceptability of chemoprophylaxis for household contacts of leprosy patients in Bangladesh: a qualitative study.
Feenstra SG; Nahar Q; Pahan D; Oskam L; Richardus JH
Lepr Rev; 2011 Jun; 82(2):178-87. PubMed ID: 21888142
[TBL] [Abstract][Full Text] [Related]
3. Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis.
Richardus JH; Oskam L
Clin Dermatol; 2015; 33(1):19-25. PubMed ID: 25432807
[TBL] [Abstract][Full Text] [Related]
4. Prevention of leprosy using rifampicin as chemoprophylaxis.
Bakker MI; Hatta M; Kwenang A; Van Benthem BH; Van Beers SM; Klatser PR; Oskam L
Am J Trop Med Hyg; 2005 Apr; 72(4):443-8. PubMed ID: 15827283
[TBL] [Abstract][Full Text] [Related]
5. Clinical manifestations of leprosy after BCG vaccination: an observational study in Bangladesh.
Richardus RA; Butlin CR; Alam K; Kundu K; Geluk A; Richardus JH
Vaccine; 2015 Mar; 33(13):1562-7. PubMed ID: 25701674
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of single-dose rifampicin after BCG vaccination to prevent leprosy in close contacts of patients with newly diagnosed leprosy: A cluster randomized controlled trial.
Richardus R; Alam K; Kundu K; Chandra Roy J; Zafar T; Chowdhury AS; Nieboer D; Faber R; Butlin CR; Geluk A; Richardus JH
Int J Infect Dis; 2019 Nov; 88():65-72. PubMed ID: 31499206
[TBL] [Abstract][Full Text] [Related]
7. Patient-related factors predicting the effectiveness of rifampicin chemoprophylaxis in contacts: 6 year follow up of the COLEP cohort in Bangladesh.
Feenstra SG; Pahan D; Moet FJ; Oskam L; Richardus JH
Lepr Rev; 2012 Sep; 83(3):292-304. PubMed ID: 23356030
[TBL] [Abstract][Full Text] [Related]
8. Chemoprophylaxis of leprosy with rifampicin in contacts of multibacillary patients: study protocol for a randomized controlled trial.
Dos Santos DS; Duppre NC; Sarno EN; Pinheiro RO; Sales AM; Nery JADC; Moraes MO; Camacho LAB
Trials; 2018 Apr; 19(1):244. PubMed ID: 29685164
[TBL] [Abstract][Full Text] [Related]
9. Comparative leprosy vaccine trial in south India.
Gupte MD; Vallishayee RS; Anantharaman DS; Nagaraju B; Sreevatsa ; Balasubramanyam S; de Britto RL; Elango N; Uthayakumaran N; Mahalingam VN; Lourdusamy G; Ramalingam A; Kannan S; Arokiasamy J
Indian J Lepr; 1998; 70(4):369-88. PubMed ID: 10189587
[TBL] [Abstract][Full Text] [Related]
10. A study on transmission and a trial of chemoprophylaxis in contacts of leprosy patients: design, methodology and recruitment findings of COLEP.
Moet FJ; Oskam L; Faber R; Pahan D; Richardus JH
Lepr Rev; 2004 Dec; 75(4):376-88. PubMed ID: 15682975
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
Zodpey SP; Ambadekar NN; Thakur A
Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132
[TBL] [Abstract][Full Text] [Related]
12. Long lasting BCG protection against leprosy.
Rodrigues LC; Kerr-Pontes LR; Frietas MV; Barreto ML
Vaccine; 2007 Sep; 25(39-40):6842-4. PubMed ID: 17728023
[TBL] [Abstract][Full Text] [Related]
13. SIMLEP: a simulation model for leprosy transmission and control.
Meima A; Gupte MD; van Oortmarssen GJ; Habbema JD
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):215-36. PubMed ID: 10575401
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of chemoprophylaxis and immunoprophylaxis in leprosy prevention: a systematic review and network meta-analysis of randomized controlled trials.
Tawfik GM; Biala M; Yousef YM; Tiwari R; Dobs M; Lotfy CI; Farrag DA; Hue AT; Yotsu RR; Huy NT
Clin Microbiol Infect; 2021 Dec; 27(12):1754-1761. PubMed ID: 34332107
[TBL] [Abstract][Full Text] [Related]
15. Leprosy.
Lockwood D
Clin Evid; 2006 Jun; (15):1079-87. PubMed ID: 16973045
[No Abstract] [Full Text] [Related]
16. Protocol, rationale and design of PEOPLE (Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar): a cluster randomized trial on effectiveness of different modalities of implementation of post-exposure prophylaxis of leprosy contacts.
Ortuno-Gutierrez N; Younoussa A; Randrianantoandro A; Braet S; Cauchoix B; Ramboarina S; Baco A; Mzembaba A; Salim Z; Amidy M; Grillone S; Richardus JH; de Jong BC; Hasker E
BMC Infect Dis; 2019 Dec; 19(1):1033. PubMed ID: 31805862
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of rifampicin chemoprophylaxis in preventing leprosy in patient contacts: a systematic review of quantitative and qualitative evidence.
Ferreira SMB; Yonekura T; Ignotti E; Oliveira LB; Takahashi J; Soares CB
JBI Database System Rev Implement Rep; 2017 Oct; 15(10):2555-2584. PubMed ID: 29035966
[TBL] [Abstract][Full Text] [Related]
18. The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study).
Richardus RA; Alam K; Pahan D; Feenstra SG; Geluk A; Richardus JH
BMC Infect Dis; 2013 Oct; 13():456. PubMed ID: 24088534
[TBL] [Abstract][Full Text] [Related]
19. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
Zodpey SP
Indian J Public Health; 2004; 48(2):70-7. PubMed ID: 15709589
[TBL] [Abstract][Full Text] [Related]
20. 10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy.
Katoch K; Katoch VM; Natrajan M; Sreevatsa ; Gupta UD; Sharma VD; Shivanavar CT
Vaccine; 2004 Sep; 22(27-28):3649-57. PubMed ID: 15315844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
